Urinary exosome-based androgen receptor-variant 7 detection in metastatic castration-resistant prostate cancer patients

BACKGROUND: Androgen receptor variant 7 (AR-V7) detection provides important information for the clinical management of abiraterone in metastatic castration-resistant prostate cancer (mCRPC). We performed a non-invasive urine-derived exosomal AR-V7 analysis of mCRPC patients. METHODS: A total of 34...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Liu, Xiang, Li, Hongyan, Zhao, Libo, Kong, Guanyi, Chen, Jing, Li, Zhi, Qi, Jianfei, Tian, Ye, Zhang, Fengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899142/
https://www.ncbi.nlm.nih.gov/pubmed/35280667
http://dx.doi.org/10.21037/tau-21-1136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899142/
https://www.ncbi.nlm.nih.gov/pubmed/35280667
http://dx.doi.org/10.21037/tau-21-1136

Ejemplares similares